# Reliance Global Group, Inc.: overview EZRA · Nasdaq · CIK 1812727 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ezra.md) · [Financials](/companies/ezra/financials.md) · [Filings](/companies/ezra/filings.md) · [Insiders](/companies/ezra/insiders.md) Latest reported revenue: [$2.1m](/filings/0001493152-26-035504.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:Revenues, accession 0001493152-26-035504). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,441](/filings/0001493152-24-044014.md) | [3,297 d](/filings/0001493152-26-009536.md) | [4,236](/filings/0001641172-25-010313.md) | [3,087](/filings/0001641172-25-021555.md) | [2,496](/filings/0001493152-25-021089.md) | [2,612 d](/filings/0001493152-26-009536.md) | [3,827](/filings/0001493152-26-021761.md) | [2,111](/filings/0001493152-26-035504.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(14.9%)](/filings/0001493152-25-021089.md) | [(30.5%) d](/filings/0001493152-26-009536.md) | [(33.2%)](/filings/0001493152-26-021761.md) | [(76.8%)](/filings/0001493152-26-035504.md) | [(156.8%)](/filings/0001493152-25-021089.md) | [(50.5%) d](/filings/0001493152-26-009536.md) | [(32.4%)](/filings/0001493152-26-021761.md) | [(86.4%)](/filings/0001493152-26-035504.md) | | Net margin | % | [(24.3%)](/filings/0001493152-25-021089.md) | [(42.4%) d](/filings/0001493152-26-009536.md) | [(41.0%)](/filings/0001493152-26-021761.md) | [(87.8%)](/filings/0001493152-26-035504.md) | [(46.3%)](/filings/0001493152-25-021089.md) | [(53.0%) d](/filings/0001493152-26-009536.md) | [(38.4%)](/filings/0001493152-26-021761.md) | [(94.3%)](/filings/0001493152-26-035504.md) | | Diluted EPS | $ per share | [(0.67)](/filings/0001493152-25-021089.md) | not reported | [(0.66)](/filings/0001493152-26-021761.md) | [(33.90)](/filings/0001493152-26-035504.md) | [(0.20)](/filings/0001493152-25-021089.md) | not reported | [(0.09)](/filings/0001493152-26-021761.md) | [(3.26)](/filings/0001493152-26-035504.md) | | Free cash flow | $k | [(762) d](/filings/0001493152-25-021089.md) | [(872) d](/filings/0001493152-26-009536.md) | [193](/filings/0001493152-26-021761.md) | [(857) d](/filings/0001493152-26-035504.md) | [(821) d](/filings/0001493152-25-021089.md) | [(1,625) d](/filings/0001493152-26-009536.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.7](/filings/0001493152-23-027450.md) | [11.8](/filings/0001493152-24-013118.md) | [13.7](/filings/0001493152-25-009445.md) | [14.1](/filings/0001493152-26-009536.md) | [12.4](/filings/0001493152-26-009536.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(30.0%)](/filings/0001493152-23-027450.md) | [(55.9%)](/filings/0001493152-24-013118.md) | [(101.1%)](/filings/0001493152-25-009445.md) | [(54.8%)](/filings/0001493152-26-009536.md) | [(72.5%)](/filings/0001493152-26-009536.md) | | Net margin | % | [(217.3%)](/filings/0001493152-23-027450.md) | [55.0%](/filings/0001493152-24-013118.md) | [(87.5%)](/filings/0001493152-25-009445.md) | [(64.5%)](/filings/0001493152-26-009536.md) | [(56.2%)](/filings/0001493152-26-009536.md) | | Diluted EPS | $ per share | [(2.09)](/filings/0001493152-22-008413.md) | [(0.42)](/filings/0001493152-24-013118.md) | [(87.70)](/filings/0001493152-25-009445.md) | [(9.01)](/filings/0001493152-26-009536.md) | [(1.28)](/filings/0001493152-26-009536.md) | | Free cash flow | $m | [(2.3)](/filings/0001493152-23-027450.md) | [(3.3)](/filings/0001493152-24-013118.md) | [(0.9)](/filings/0001493152-25-009445.md) | [(2.5)](/filings/0001493152-26-009536.md) | [(3.1)](/filings/0001493152-26-009536.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ezra/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Vinva Investment Management Ltd](/funds/1968109.md) | 2026-06-30 | $592.7k | 1,583 | | New +1,583 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $61.8k | 19,027 | | New +19,027 | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $17.1k | 5,266 | | New +5,266 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $16.7k | 5,133 | | New +5,133 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $10.6k | 3,269 | | New +3,269 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $6.6k | 2,040 | | New +2,040 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $1.4k | 418 | | New +418 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $20 | 6 | | New +6 | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $13 | 4 | | New +4 | | [Stonehage Fleming Financial Services Holdings Ltd](/funds/1786379.md) | 2026-06-30 | $9 | 3 | | New +3 | ## Recent filings [All 386 filings](/companies/ezra/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 16:05 ET | [8-K](/filings/0001493152-26-048229.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-048229 | | 2026-10-15 | 19:11 ET | [SCHEDULE 13D/A](/filings/0001096906-26-001556.md) | Ownership report, active investor, amended | 0001096906-26-001556 | | 2026-10-15 | 17:43 ET | [SCHEDULE 13D/A](/filings/0001096906-26-001553.md) | Ownership report, active investor, amended | 0001096906-26-001553 | | 2026-10-13 | 10:30 ET | [8-K](/filings/0001493152-26-046708.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-046708 | | 2026-10-05 | 21:27 ET | [8-K](/filings/0001493152-26-045782.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045782 | | 2026-09-30 | 13:20 ET | [8-K/A](/filings/0001493152-26-045046.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-045046 | | 2026-09-30 | 21:51 ET | [8-K](/filings/0001493152-26-044941.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-044941 | | 2026-09-16 | 13:00 ET | [8-K](/filings/0001493152-26-042846.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042846 | | 2026-09-11 | 13:37 ET | [8-K](/filings/0001493152-26-042319.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-042319 | | 2026-09-09 | 13:59 ET | [8-K](/filings/0001493152-26-041914.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041914 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-009536.md), filed Mar 10, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e55ba643-208b-472d-a996-4ee8272bd633) ## About the filer - CIK: 1812727 - Tickers: EZRA - Exchange: Nasdaq - SIC code: 6411 Insurance Agents, Brokers & Service - State of incorporation: FL - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.